| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks | Director | Chief Financial Officer
2 companies
Thunen Shelley B is a See Remarks at RxSight, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 26 sells.
Estimated insider holdings value: $214K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 1, 2024 | RXST Rxsight, Inc. | See Remarks | Sale+OE | 15,000 | $48.45 | $726,729.73 | -12.9% | -28.3% | -80.9% | |
| Jul 1, 2024 | RXST Rxsight, Inc. | Chief Financial Officer | Sale+OE | 18,402 | $58.68 | $1,079,815.65 | -36.9% | -13.0% | -76.9% | |
| May 1, 2024 | RXST Rxsight, Inc. | Chief Financial Officer | Sale+OE | 10,000 | $52.69 | $526,912.72 | -26.1% | -20.6% | -73.6% | |
| Apr 1, 2024 | RXST Rxsight, Inc. | Chief Financial Officer | Sell | 20,000 | $49.90 | $997,946.23 | -21.1% | +12.5% | -50.0% | |
| Mar 1, 2024 | RXST Rxsight, Inc. | Chief Financial Officer | Sale+OE | 10,000 | $56.37 | $563,725.65 | -16.0% | +6.9% | -49.1% | |
| Feb 6, 2024 | RXST Rxsight, Inc. | Chief Financial Officer | Sale+OE | 25,000 | $47.31 | $1,182,660.25 | -47.7% | +32.3% | -27.9% | |
| Jan 26, 2024 | RXST Rxsight, Inc. | Chief Financial Officer | Sale+OE | 31,772 | $47.11 | $1,496,705.84 | -82.4% | +10.2% | -31.0% | |
| Jan 2, 2024 | RXST Rxsight, Inc. | Chief Financial Officer | Sale+OE | 10,000 | $39.24 | $392,408.75 | -49.8% | +37.7% | -5.7% | |
| Dec 15, 2023 | RXST Rxsight, Inc. | Chief Financial Officer | Sale+OE | 40,000 | $39.33 | $1,573,310.00 | -36.7% | +16.3% | -6.1% |